NCT06779721 is a clinical trial of Sestrin-2 in Obese Adolescents, sponsored by Kayseri City Hospital.

Who is sponsoring NCT06779721?

NCT06779721 is sponsored by Kayseri City Hospital.

What drugs are being tested in NCT06779721?

Interventions in NCT06779721: Sestrin-2.

What condition does NCT06779721 study?

NCT06779721 studies Obese Adolescents.

Is NCT06779721 still recruiting?

NCT06779721 is currently completed. Last updated 17 January 2025.

Last reviewed 2025-01-17 · How we verify

NCT06779721

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sestrin-2 Levels and Insulin Resistance

Completed Last updated 17 January 2025

What this trial tests

trial testing Sestrin-2 in Obese Adolescents in 89 participants. Completed in 15 February 2022.

Timeline

20 June 2021

Primary endpoint
20 January 2022

15 February 2022

Quick facts

Lead sponsor	Kayseri City Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	89
Start date	20 June 2021
Primary completion	20 January 2022
Estimated completion	15 February 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Sestrin-2

Conditions studied

Obese Adolescents — all drugs for Obese Adolescents →

Sponsor

Kayseri City Hospital

Who can join

Adults 10 to 18, any sex, with Obese Adolescents. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate sestrin-2 levels in children with obesity

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Sestrin-2 levels and insulin resistance in childhood obesity.
Soylu Ustkoyuncu P, Kocer D. · · 2026 · PMID 40621934 · DOI 10.1177/10815589251359311

Verify or expand the search:

Other recruiting trials for Obese Adolescents

Currently open trials in the same condition.

NCT06755827 — Pilot Testing a Novel Approach to Pediatric Obesity Treatment · Phase 1, PHASE2 · recruiting
NCT07143227 — A Study of XW003 Injection in Chinese Adolescents With Obesity · Phase 1 · active not recruiting

Other Kayseri City Hospital trials

Trials by the same sponsor.

NCT07508397 — Median Nerve Cross-Sectional Area and Body Weight in Carpal Tunnel Syndrome · not yet recruiting
NCT07440758 — Low-Flow Sevoflurane and Desflurane Anesthesia in Laparoscopic Cholecystectomy · NA · not yet recruiting
NCT07489248 — Multimodal Ultrasound for Differentiating Lymphedema and Lipedema · recruiting
NCT07445659 — qCON/qNOX-Guided Anesthesia in Patients Undergoing Thyroidectomy Surgery · NA · not yet recruiting
NCT07368413 — Comparison of the Analgesic Efficacy of Erector Spinae Plane Block in Breast-Conserving Surgery Versus Serratus Anterior · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06779721 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kayseri City Hospital
Last refreshed: 17 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06779721.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing